Summary
Updated Aug 31, 2026
Vlad Coric is Director of Royalty Pharma plc (RPRX). 5 SEC Form 4 filings on record going back to 2024, most recently on 8 June 2026. Most recent open-market trade: bought $1000K of MANE on 6 February 2026. Lifetime open-market purchases: $8.00M. Historical track record: 5/5 stars across 5 tracked purchases.
Recent Transactions
13Every recent SEC Form 4 transaction Vlad Coric has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 100% |
| 90-day win rate | 80% |
| Avg 5-day return | +12.31% |
| Avg 30-day return | +32.29% |
| Avg 90-day return | +92.04% |
| Best 30-day return | +39.60% |
Trading Pattern
InsiderAlpha's records for Vlad Coric go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $1.60M (5 buys totaling $8.00M). The largest single buy on record is $2.50M of BHVN in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Vlad Coric files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Christopher Hite - $21.50M of RPRX open-market activity in the last 12 months
- George W. Lloyd - $9.57M of RPRX open-market activity in the last 12 months
- Marshall Urist - $6.54M of RPRX open-market activity in the last 12 months
- Gregory Norden - $161K of RPRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Vlad Coric?
Vlad Coric is a corporate insider, tracked as Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vlad Coric submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Vlad Coric been buying or selling stock?
Recorded transactions: 5 open-market purchases ($8.00M) and 0 open-market sales across all tracked filings.
How accurate is Vlad Coric's historical track record?
Across 5 tracked purchases, Vlad Coric averaged +32.3% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Vlad Coric's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Vlad Coric and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial